- Instruments
- Software
- Assays & Reagents
Infectious Disease Diagnostics market was valued at USD 14,007.8 million in 2022 and is poised to grow at a CAGR of 4.4% over 2023-2029. A diagnostic is a laboratory test used to diagnose infectious illnesses with the assistance of trained technicians and clinicians. It is a diagnostic method that involves identifying and characterizing the infectious disease's causing organism. Various diagnostic procedures and devices are used to test a sample of urine, blood, mucus, or other bodily fluids to determine the causing organism. Based on the disease type HIV/AIDS is anticipated to show a significant growth rate in the market share over the forecasting period. According to the Minority of HIV/AIDS Fund (MHAF), United States Department of Health and Human Services Statistics, revised in June 2021, there were an estimated 37.6 million individuals living with HIV Diagnostics in the globe in 2020, including 35.9 million adults and 1.7 million children (under 15 years old). Moreover, the company are focusing in launching new products to maintain growth in the market In March 2021, Roche Diagnostics Launched Cobas SARS-CoV-2 Variant Set 1 Test to help monitor emerging coronavirus mutations. The growing prevalence of infectious diseases, greater understanding of the diagnosis increases in government funding, rising healthcare costs, and increasing adoption of technologically advanced diagnostic equipment in healthcare organizations also heighten the overall growth of the market.
Infectious Disease Diagnostics Market Recent Key Developments:
In February 2021, Thermo Fisher Scientific acquired Mesa Biotech (US) to expand the benefits of molecular diagnostics at the point of care.
In March 2020, Abbott Laboratories launched the ID NOW COVID-19 Test.
Global Infectious Disease Diagnostics Market Summary
Study Period
2023-29
Base Year
2022
CAGR
4.4%
Largest Market
North America
Fastest Growing Market
Canada
Infectious Disease Diagnostics Market Dynamics
The market is expected to rise as the number of medical laboratories practicing infectious disease diagnostic tests have been increased. Increased prevalence of infectious diseases such as hepatitis, influenza, COVID-19, and HIV; increased demand for infection diagnostic tests; increased funding from private and government organizations for diagnostic service centers; and advancements in infectious disease diagnostic technologies. Have also anticipated grow the market in the forecasting period. Moreover, In order to improve COVID-19 testing capacity, the Indian government announced the opening of three state-of-the-art high throughput Indian Council of Medical Research laboratories in Kolkata, Mumbai, and Noida in 2020.
Infectious Disease Diagnostics Market Regional Analysis
North-America Got Significant Share
North America accounted to have a significant share of the global infections disease diagnostics market and the market is expected to grow at a significant CAGR over the forecast years owing to the highly developed healthcare systems in the United States and Canada, as well as the presence of numerous prominent national clinical labs and easy access to technologically advanced instruments, have all contributed to the industry's success.
Latin America
Europe
Asia Pacific
Middle East
North America
Key Features of the Reports
- The report provides granular level information about the market size, regional market share, historic market (2018 to 2022) and forecast (2023 to 2029)
- The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
- The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
- The report tracks recent innovations, key developments and startup’s details that are actively working in the market
- The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
- The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market
Global Infectious Disease Diagnostics Market Segmentation
By Product Type
By Disease Type
- HIV, Hepatitis
- Tuberculosis
- Human papillomavirus infection
- Influenza A&B
- Sexually Transmitted Diseases
- and Others
By Technology
- Immunodiagnostics
- Clinical Microbiology
- Polymerase Chain Reaction
- Next Generation Sequencing
- Others
By Geography
- North America
- Europe
- Asia Pacific
- Latin America
- MEA
Frequently Asked Questions
The infectious disease diagnostics market is projected to expand at a CAGR of 4.4% during the forecast period.
Abbott Laboratories, Becton Dickinson and Company, bioMerieus SA, Bio-Rad Laboratories, Danaher Corporation, F Hoffman-La Roche
North America is the fastest-growing region for infectious disease diagnostics market
The development and launch of point-of-care diagnostic instruments and kits is a key opportunity for companies to enhance their revenue. over the forecast years
Increase in the adoption of molecular diagnostic test kits such as PCR kits for accurate results compared with other diagnostic techniques is a major trend in the infectious disease diagnosis market.
| 1. Executive Summary |
| 2. Global Infectious Disease Diagnostics Market Introduction |
| 2.1. Global Infectious Disease Diagnostics Market – Taxonomy |
| 2.2. Global Infectious Disease Diagnostics Market –Definitions |
| 2.2.1. Product Type |
| 2.2.2. Testing Type |
| 2.2.3. Technology |
| 2.2.4. Disease Type |
| 2.2.5. End User |
| 3. Global Infectious Disease Diagnostics Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Global Infectious Disease Diagnostics Market Dynamic Factors - Impact Analysis |
| 3.6. Global Infectious Disease Diagnostics Market – Competition Landscape |
| 4. Global Infectious Disease Diagnostics Market Analysis,2017 - 2021 and Forecast, 2022 - 2028 |
| 4.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
| 4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5. Global Infectious Disease Diagnostics Market, By Product Type, 2017–2021and Forecast, 2022–2028 (Revenue, USD Mn) |
| 5.1. Assays, Kits, & Reagents |
| 5.1.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
| 5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Instruments |
| 5.2.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
| 5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 5.3. Services & Software |
| 5.3.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
| 5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.3. Market Opportunity Analysis |
| 6. Global Infectious Disease Diagnostics Market, By Testing Type, 2017 – 2021 and Forecast, 2021 – 2027 (Revenue, USD Mn) |
| 6.1. Laboratory Testing |
| 6.1.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
| 6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. POC Testing |
| 6.2.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
| 6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 7. Global Infectious Disease Diagnostics Market Forecast, By Technology,2017–2021and Forecast, 2022–2028 (Revenue, USD Mn) |
| 7.1. Immunodiagnostics |
| 7.1.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
| 7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Clinical Microbiology |
| 7.2.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
| 7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. PCR |
| 7.3.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
| 7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 7.4. INAAT |
| 7.4.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
| 7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.4.3. Market Opportunity Analysis |
| 7.5. DNA Sequencing & NGS |
| 7.5.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
| 7.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.5.3. Market Opportunity Analysis |
| 7.6. Others |
| 7.6.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
| 7.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.6.3. Market Opportunity Analysis |
| 8. Global Infectious Disease Diagnostics Market Forecast, By Disease Type, 2017 – 2021 and Forecast, 2021 – 2027 (Revenue, USD Mn) |
| 8.1. COVID-19 |
| 8.1.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
| 8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.1.3. Market Opportunity Analysis |
| 8.2. HIV |
| 8.2.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
| 8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.2.3. Market Opportunity Analysis |
| 8.3. HAIs |
| 8.3.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
| 8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.3.3. Market Opportunity Analysis |
| 8.4. Hepatitis |
| 8.4.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
| 8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.4.3. Market Opportunity Analysis |
| 8.5. STDs |
| 8.5.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
| 8.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.5.3. Market Opportunity Analysis |
| 8.6. HPV |
| 8.6.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
| 8.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.6.3. Market Opportunity Analysis |
| 8.7. TB |
| 8.7.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
| 8.7.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.7.3. Market Opportunity Analysis |
| 8.8. Influenza |
| 8.8.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
| 8.8.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.8.3. Market Opportunity Analysis |
| 8.9. Others |
| 8.9.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
| 8.9.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.9.3. Market Opportunity Analysis |
| 9. Global Infectious Disease Diagnostics Market, By End User, 2017 – 2021 and Forecast, 2021 – 2027 (Revenue, USD Mn) |
| 9.1. Diagnostic Laboratories |
| 9.1.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
| 9.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.1.3. Market Opportunity Analysis |
| 9.2. Hospitals & Clinics |
| 9.2.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
| 9.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.2.3. Market Opportunity Analysis |
| 9.3. Academic Research Institutes |
| 9.3.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
| 9.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.3.3. Market Opportunity Analysis |
| 9.4. Others |
| 9.4.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
| 9.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.4.3. Market Opportunity Analysis |
| 10. Global Infectious Disease Diagnostics Market Forecast, By Region, 2017–2021and Forecast, 2022–2028(Revenue, USD Mn) |
| 10.1. North America |
| 10.1.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
| 10.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 10.1.3. Market Opportunity Analysis |
| 10.2. Europe |
| 10.2.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
| 10.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 10.2.3. Market Opportunity Analysis |
| 10.3. Asia-Pacific |
| 10.3.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
| 10.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 10.3.3. Market Opportunity Analysis |
| 10.4. Latin America |
| 10.4.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
| 10.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 10.4.3. Market Opportunity Analysis |
| 10.5. Middle East and Africa |
| 10.5.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
| 10.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 10.5.3. Market Opportunity Analysis |
| 10.6. Global Infectious Disease Diagnostics Market - Opportunity Analysis Index, By Product Type, Testing Type, Technology, Disease Type, End User and Region, 2022 - 2028 |
| 11. North America Infectious Disease Diagnostics MarketAnalysis,2017–2021and Forecast, 2022–2028(Revenue, USD Mn) |
| 11.1. Product Type Analysis 2017–2021and Forecast 2022 - 2028by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1. Assays, Kits, & Reagents |
| 11.1.2. Instruments |
| 11.1.3. Services & Software |
| 11.2. Testing Type Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 11.2.1. Laboratory Testing |
| 11.2.2. POC Testing |
| 11.3. Technology Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 11.3.1. Immunodiagnostics |
| 11.3.2. Clinical Microbiology |
| 11.3.3. PCR |
| 11.3.4. INAAT |
| 11.3.5. DNA Sequencing & NGS |
| 11.3.6. Others |
| 11.4. Disease Type Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 11.4.1. COVID-19 |
| 11.4.2. HIV |
| 11.4.3. HAIs |
| 11.4.4. Hepatitis |
| 11.4.5. STDs |
| 11.4.6. HPV |
| 11.4.7. TB |
| 11.4.8. Influenza |
| 11.4.9. Others |
| 11.5. End User Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 11.5.1. Diagnostic Laboratories |
| 11.5.2. Hospitals & Clinics |
| 11.5.3. Academic Research Institutes |
| 11.5.4. Others |
| 11.6. Country Analysis 2017 - 2021 and Forecast 2022 - 2028by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 11.6.1. USA |
| 11.6.2. Canada |
| 11.7. North America Infectious Disease Diagnostics Market - Opportunity Analysis Index, By Product Type, Testing Type, Technology, Disease Type, End User and Country, 2022 - 2028 |
| 11.8. North America Infectious Disease Diagnostics Market Dynamics – Trends |
| 12. Europe Infectious Disease Diagnostics Market Analysis, 2017–2021and Forecast, 2022–2028(Revenue, USD Mn) |
| 12.1. Product Type Analysis 2017–2021and Forecast 2022 - 2028by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1. Assays, Kits, & Reagents |
| 12.1.2. Instruments |
| 12.1.3. Services & Software |
| 12.2. Testing Type Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 12.2.1. Laboratory Testing |
| 12.2.2. POC Testing |
| 12.3. Technology Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 12.3.1. Immunodiagnostics |
| 12.3.2. Clinical Microbiology |
| 12.3.3. PCR |
| 12.3.4. INAAT |
| 12.3.5. DNA Sequencing & NGS |
| 12.3.6. Others |
| 12.4. Disease Type Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 12.4.1. COVID-19 |
| 12.4.2. HIV |
| 12.4.3. HAIs |
| 12.4.4. Hepatitis |
| 12.4.5. STDs |
| 12.4.6. HPV |
| 12.4.7. TB |
| 12.4.8. Influenza |
| 12.4.9. Others |
| 12.5. End User Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 12.5.1. Diagnostic Laboratories |
| 12.5.2. Hospitals & Clinics |
| 12.5.3. Academic Research Institutes |
| 12.5.4. Others |
| 12.6. Country Analysis 2017–2021and Forecast 2022 - 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 12.6.1. Germany |
| 12.6.2. UK |
| 12.6.3. France |
| 12.6.4. Spain |
| 12.6.5. Italy |
| 12.6.6. Russia |
| 12.6.7. Poland |
| 12.6.8. Rest of Europe |
| 12.7. Europe Infectious Disease Diagnostics Market - Opportunity Analysis Index, By Product Type, Testing Type, Technology, Disease Type, End Userand Country, 2022 - 2028 |
| 12.8. Europe Infectious Disease Diagnostics Market Dynamics – Trends |
| 13. Asia-Pacific Infectious Disease Diagnostics Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
| 13.1. Product Type Analysis 2017–2021and Forecast 2022 - 2028by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%) |
| 13.1.1. Assays, Kits, & Reagents |
| 13.1.2. Instruments |
| 13.1.3. Services & Software |
| 13.2. Testing Type Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 13.2.1. Laboratory Testing |
| 13.2.2. POC Testing |
| 13.3. Technology Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 13.3.1. Immunodiagnostics |
| 13.3.2. Clinical Microbiology |
| 13.3.3. PCR |
| 13.3.4. INAAT |
| 13.3.5. DNA Sequencing & NGS |
| 13.3.6. Others |
| 13.4. Disease Type Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 13.4.1. COVID-19 |
| 13.4.2. HIV |
| 13.4.3. HAIs |
| 13.4.4. Hepatitis |
| 13.4.5. STDs |
| 13.4.6. HPV |
| 13.4.7. TB |
| 13.4.8. Influenza |
| 13.4.9. Others |
| 13.5. End User Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 13.5.1. Diagnostic Laboratories |
| 13.5.2. Hospitals & Clinics |
| 13.5.3. Academic Research Institutes |
| 13.5.4. Others |
| 13.6. Country Analysis2017–2021and Forecast 2022 - 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 13.6.1. Japan |
| 13.6.2. China |
| 13.6.3. India |
| 13.6.4. ASEAN |
| 13.6.5. Australia & New Zealand |
| 13.6.6. Rest of Asia-Pacific |
| 13.7. Asia-Pacific Infectious Disease Diagnostics Market - Opportunity Analysis Index, By Product Type, Testing Type, Technology, Disease Type, End User and Country,2022 - 2028 |
| 13.8. Asia-Pacific Infectious Disease Diagnostics Market Dynamics – Trends |
| 14. Latin America Infectious Disease Diagnostics Market Analysis,2017 - 2021 and Forecast, 2022–2028(Revenue, USD Mn) |
| 14.1. Product Type Analysis 2017–2021and Forecast 2022 - 2028by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%) |
| 14.1.1. Assays, Kits, & Reagents |
| 14.1.2. Instruments |
| 14.1.3. Services & Software |
| 14.2. Testing Type Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 14.2.1. Laboratory Testing |
| 14.2.2. POC Testing |
| 14.3. Technology Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 14.3.1. Immunodiagnostics |
| 14.3.2. Clinical Microbiology |
| 14.3.3. PCR |
| 14.3.4. INAAT |
| 14.3.5. DNA Sequencing & NGS |
| 14.3.6. Others |
| 14.4. Disease Type Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 14.4.1. COVID-19 |
| 14.4.2. HIV |
| 14.4.3. HAIs |
| 14.4.4. Hepatitis |
| 14.4.5. STDs |
| 14.4.6. HPV |
| 14.4.7. TB |
| 14.4.8. Influenza |
| 14.4.9. Others |
| 14.5. End User Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 14.5.1. Diagnostic Laboratories |
| 14.5.2. Hospitals & Clinics |
| 14.5.3. Academic Research Institutes |
| 14.5.4. Others |
| 14.6. Country Analysis 2017–2021and Forecast 2022 - 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 14.6.1. Brazil |
| 14.6.2. Mexico |
| 14.6.3. Argentina |
| 14.6.4. Rest of Latin America |
| 14.7. Latin America Infectious Disease Diagnostics Market - Opportunity Analysis Index, By Product Type, Testing Type, Technology, Disease Type, End User and Country, 2022 - 2028 |
| 14.8. Latin America Infectious Disease Diagnostics Market Dynamics – Trends |
| 15. Middle East and Africa Infectious Disease Diagnostics Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
| 15.1. Product Type Analysis 2017–2021and Forecast 2022 - 2028by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%) |
| 15.1.1. Assays, Kits, & Reagents |
| 15.1.2. Instruments |
| 15.1.3. Services & Software |
| 15.2. Testing Type Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 15.2.1. Laboratory Testing |
| 15.2.2. POC Testing |
| 15.3. Technology Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 15.3.1. Immunodiagnostics |
| 15.3.2. Clinical Microbiology |
| 15.3.3. PCR |
| 15.3.4. INAAT |
| 15.3.5. DNA Sequencing & NGS |
| 15.3.6. Others |
| 15.4. Disease Type Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 15.4.1. COVID-19 |
| 15.4.2. HIV |
| 15.4.3. HAIs |
| 15.4.4. Hepatitis |
| 15.4.5. STDs |
| 15.4.6. HPV |
| 15.4.7. TB |
| 15.4.8. Influenza |
| 15.4.9. Others |
| 15.5. End User Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 15.5.1. Diagnostic Laboratories |
| 15.5.2. Hospitals & Clinics |
| 15.5.3. Academic Research Institutes |
| 15.5.4. Others |
| 15.6. Country Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 15.6.1. Gulf Cooperation Council (GCC) Countries |
| 15.6.2. Israel |
| 15.6.3. South Africa |
| 15.6.4. Rest of MEA |
| 15.7. MEA Infectious Disease Diagnostics Market - Opportunity Analysis Index, By Product Type, Testing Type, Technology, Disease Type, End User and Country, 2022 - 2028 |
| 15.8. MEA Infectious Disease Diagnostics Market Dynamics – Trends |
| 16. Competition Landscape |
| 16.1. Strategic Dashboard of Top Market Players |
| 16.2. Company Profiles (Introduction, Financial Analysis, Product Type& Service Testing Types, Key Developments, Strategies, and SWOT Analysis) |
| 16.2.1. Abbott Laboratories |
| 16.2.2. Becton Dickinson and Company |
| 16.2.3. bioMerieus SA |
| 16.2.4. Bio-Rad Laboratories |
| 16.2.5. Danaher Corporation |
| 16.2.6. F Hoffman-La Roche |
| 16.2.7. Hologic Inc. |
| 16.2.8. Luminex Corporation |
| 16.2.9. Qiagen Inc. |
| 16.2.10. Thermo Fisher Scientific Inc. |
| 16.2.11. LumiraDx |
| 17. Research Methodology |
| 18. Key Assumptions and Acronyms |
- Abbott Laboratories
- Becton Dickinson and Company
- BioMerieus SA
- Bio-Rad Laboratories
- Danaher Corporation
- F Hoffman-La Roche
- Hologic Inc.
- Luminex Corporation
- Qiagen Inc
- Thermo Fisher Scientific Inc.
- LumiraDx